1. Home
  2. BRBS vs CABA Comparison

BRBS vs CABA Comparison

Compare BRBS & CABA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

BRBS

Blue Ridge Bankshares Inc.

HOLD

Current Price

$3.33

Market Cap

293.1M

Sector

Finance

ML Signal

HOLD

Logo Cabaletta Bio Inc.

CABA

Cabaletta Bio Inc.

HOLD

Current Price

$3.20

Market Cap

319.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BRBS
CABA
Founded
1893
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Commercial Banks
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
293.1M
319.6M
IPO Year
2015
2019

Fundamental Metrics

Financial Performance
Metric
BRBS
CABA
Price
$3.33
$3.20
Analyst Decision
Strong Buy
Analyst Count
0
6
Target Price
N/A
$14.50
AVG Volume (30 Days)
200.9K
3.4M
Earning Date
04-23-2026
05-14-2026
Dividend Yield
24.78%
N/A
EPS Growth
135.48
10.26
EPS
0.01
N/A
Revenue
$111,284,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$329.00
N/A
Revenue Growth
123.99
N/A
52 Week Low
$3.23
$1.26
52 Week High
$4.79
$4.23

Technical Indicators

Market Signals
Indicator
BRBS
CABA
Relative Strength Index (RSI) 46.44 39.92
Support Level $3.23 $3.12
Resistance Level $3.33 $3.48
Average True Range (ATR) 0.05 0.27
MACD 0.02 -0.08
Stochastic Oscillator 80.00 17.56

Price Performance

Historical Comparison
BRBS
CABA

About BRBS Blue Ridge Bankshares Inc.

Blue Ridge Bankshares Inc is a United States-based company engaged in offering commercial and consumer banking and financial services through its wholly-owned bank subsidiary and its non-bank financial services affiliates. The bank offers services such as checking accounts, savings accounts, money market accounts, cash management accounts, commercial and industrial loans, residential mortgages, commercial mortgages, home equity loans, consumer installment loans, investment accounts, insurance, and others. It generates the majority of its revenue from commercial banking.

About CABA Cabaletta Bio Inc.

Cabaletta Bio Inc is a clinical-stage biotechnology company focused on the discovery and development of engineered T cell therapies and exploring their potential to provide a deep and durable, perhaps curative, treatment for patients with B cell-mediated autoimmune diseases. Its proprietary technology utilizes Chimeric AutoAntibody Receptor, or CAART cells, that are designed to selectively bind and eliminate only specific B cells that produce disease-causing autoantibodies, or pathogenic B cells, while sparing normal B cells. Its CABA platform encompasses two strategies: CARTA (chimeric antigen receptor T cells for autoimmunity) and CAART (chimeric autoantibody T cells) that have the potential to be applied across a broad range of autoimmune diseases.

Share on Social Networks: